Dry Powder Inhalers are widely used to locally deliver medecines to treat patients with conditions such as Asthma and COPD. The most common types of devices are blister, reservoir and capsule-based devices, such as H&T Presspart’s PowdAir Plus.

Classic dry powder formulations are carrier-based but the market is evolving towards new particle engineering and powder processing methods. This poses new challenges to the DPI devices to ensure a high lung deposition of the delivered drug.

H&T Presspart has developed its own innovative high performance dry powder technology to answer those market needs and is working in partnership with global Pharma companies to co-develop and industrialise the next generation of DPI devices.